Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Marie Skłodowska-Curie Action · Running

AstroCirc ASTROcytes in CIRCuits: Unraveling their contribution in healthy and diseased brain circuits.

Coordinator
I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do Porto, Portugal
Runs
1 January 2027 to 31 December 2030
Status
Running
EU funding
€4.5m
Total cost
—
Partners
27 organisations in 11 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101311468

What the project is doing

In the project's own words, from its summary on CORDIS.

In 2021, an estimated 3.4 billion people—about 43% of the world’s population—were living with a neurological condition, underscoring the need for new strategies to understand and treat brain disorders. Decades of predominantly neuron-centric research have not delivered the breakthroughs required to reduce their growing global burden. AstroCirc proposes a shift toward a more complete view of brain circuitry by integrating the roles of astrocytes—the most abundant non-neuronal cells, essential for brain homeostasis and circuit dynamics.

By leveraging astrocyte function, AstroCirc aims to uncover novel disease mechanisms and develop astrocyte-based, disease-modifying therapeutic strategies, expanding the options available to tackle neurological diseases. AstroCirc will train 15 doctoral candidates (DCs) in astrocyte–neuron interactions and neural circuitry, building on the project’s cross-disciplinary and intersectoral framework. DCs will be mentored by leading experts in glial biology and will access advanced methodologies and unique model systems across the consortium.

Their research will span multiple levels of brain organization: from synaptic function as the basic unit of circuits (WP1), to circuit integration within brain networks (WP2), and finally to the development of astrocyte-informed interventions for a broad variety of neurological, neuropsychiatric, and neurodegenerative disorders (WP3). AstroCirc’s impact will be reflected in DCs equipped with strong technical and transferable skills, positioning them for successful careers beyond the project.

Ultimately, AstroCirc will foster a new generation of researchers who drive and advocate for glia-centered approaches within European research and innovation.

Who is involved

OrganisationCityCountryRole
I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do PortoPortoPortugalCoordinator
Technische Universitaet GrazGrazAustriaParticipant
Universitat WienWienAustriaParticipant
Gliapharm SAGenevaSwitzerlandAssociatedpartner
Biotechnologicky Ustav Av Cr VviVestecCzechiaParticipant
Univerzita KarlovaPraha 1CzechiaAssociatedpartner
Hogan Lovells International LLPFrankfurt am MainGermanyAssociatedpartner
Klinikum Der Universitaet RegensburgRegensburgGermanyParticipant
PHIO scientific GmbHMünchenGermanyAssociatedpartner
Synaptic SystemsGöttingenGermanyAssociatedpartner
Universitaet RegensburgRegensburgGermanyAssociatedpartner
Achucarro Basque Center for Neuroscience FundazioaLeioaSpainParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Universidad Complutense De MadridMadridSpainAssociatedpartner
Universidad Del Pais Vasco/ Euskal Herriko UnibertsitateaLeioaSpainAssociatedpartner
The Hebrew University of JerusalemJerusalemIsraelParticipant
Aziende Chimiche Riunite Angelini Francesco - A.c.r.a.f. - SpARomaItalyAssociatedpartner
Universita Degli Studi Di CataniaCataniaItalyParticipant
Thelial BVWageningenNetherlandsAssociatedpartner
Norges Teknisk-Naturvitenskapelige Universitet NTNUTrondheimNorwayParticipant
Associação AccelbioCantanhedePortugalAssociatedpartner
Faculdade De Medicina Da Universidade De LisboaLisboaPortugalParticipant
Humanized Solutions, LdaCharneca Da CaparicaPortugalAssociatedpartner
Universidade Do PortoPortoPortugalAssociatedpartner
Bit Bio LimitedGirtonUnited KingdomAssociatedpartner
John Wiley and Sons LtdChichesterUnited KingdomAssociatedpartner
King's College LondonLondonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI